Clinton choice for VP signed Virginia bill to mandate HPV vaccine for 6th grade

Rhode Islanders against mandated HPV vaccinations does not endorse any particular presidential candidate, but when the potential Vice President finds it acceptable to mandate Gardasil……. then we feel you need know that. If he is okay with bypassing your parental rights of choice for something that can not impact the classroom; then how well will your parental rights be respected in over all retrospect? Hillary Clinton accepts more money in her campaign from pharmaceutical companies then any other candidate. You need to vote for what you feel is the best choice, just as you need to choose what is the best choice for your family to get the Gardasil vaccine or not.


Clinton chose Virginia Senator Tim Kaine. Kaine has a history of sinister idealogy. In fact, he once forced sixth grade girls to take Gardasil shots, according to a 2007 article from the Washington Post. (see below)

In 2006, Kaine accepted  $12,000 from Teva Pharmaceuticals TEVA, +0.18% to cover his expenses at the Democratic Governors Association meeting. A third of his donations come from big banks, or “securities and investments.” In Virginia, accepting gifts from special interest is considered a non-issue. 

“During his eight years as lieutenant governor and governor, Sen. Kaine went beyond the requirements of Virginia law, even publicly disclosing gifts of value beneath the reporting threshold,” a spokesperson told Politico. “He’s confident that he met both the letter and the spirit of Virginia’s ethical standards.”

According to CBSNews.

The disclosures showed he received an $18,000 Caribbean vacation from Virginia-based tech investor James Murray, Jr., and in 2007 received $5,500 in clothing from Stuart Siegel of S&K Menswear, a company that declared bankruptcy in 2009. Teva Pharmaceuticals gave $12,000 for expenses incurred for the Democratic Governors Association meeting in Aspen in 2006. Obama for America had the largest disclosure–$45,075 for travel and lodging related to the 2008 presidential campaign.

Kaine Says He’ll Sign Bill Making Shots Mandatory

By Tim Craig

Washington Post Staff Writer
Saturday, March 3, 2007

RICHMOND, March 2 — Virginia Gov. Timothy M. Kaine said Friday that he has decided to sign legislation requiring all sixth-grade girls to get immunized against a virus that causes cervical cancer if their parents don’t object.

Kaine (D) had expressed “some qualms” this week about mandating that girls receive the human papillomavirus vaccine before entering high school, but he said many of those concerns were alleviated after he studied the bill closer.

“The particular language that ended up in the bill is fine,” Kaine said today. “It’s very broad, and people get information about the health benefits and any health concerns about the vaccination, and they get to make their own decisions. I think that is the right balance.”

Virginia will become the second state to require the vaccine, which is called Gardasil. Last month, Texas Gov. Rick Perry (R) said girls in that state would also be required to receive it. At least 20 states and the District are studying similar proposals.

 New Jersey-based pharmaceutical maker Merck & Co. received federal approval in June to sell the vaccine. Merck began a nationwide lobbying campaign to try to get states to mandate the vaccine. Merck suspended its campaign two weeks ago amid questions about whether profit, instead of public health, is guiding the debate.

In Virginia, parents will be able to opt out of the requirement without citing a reason.

“If they choose not to do it, they don’t have to do it,” said Del. Phillip A. Hamilton (R-Newport News), the sponsor of the legislation. “They just have to sign a form so the health department knows they opted out.”

HPV is a sexually transmitted virus that causes almost 7,000 cases of cervical cancer annually. A federal study released Wednesday estimated that 7.5 million girls and women ages 14 to 24 have been infected with the virus.

Because the virus is transmitted through sexual contact, some parents and politicians worry that mandating the vaccine might encourage promiscuity. But a bipartisan majority in the General Assembly voted overwhelmingly in favor of the mandate.

The bill would take effect in 2008, making the 2008-09 school year the first that girls would be required to receive the vaccine. Supporters said that provides officials enough time to study side effects.

NACCHO HPV Stance – a statement from a group you’ll wish didn’t exist.

NACCHO HPV Stance – a statement from a group you’ll wish didn’t exist.

NACCHO HPV Statement of Policy

Below you will read, what you will not believe. The recent HPV mandate proposal in a PA county….. well this might have been some motivation. #InformedConsent becomes a job for parents and patients everywhere. Is this how it should be? The only way to stop the mandates and the infringements on our civil rights is to take the job around informed consent seriously. Do NOT stop asking questions, do NOT believe everything your doctor tells you. Much of what they are taught was a paid for message or something that comes down from a group or organization they trust, one they may not have investigated the motives or money trail of. Please read below in full, and be on the look out for what this group could encourage in the future.



Increasing HPV Vaccination Rates in Males and Females


The National Association of County and City Health Officials (NACCHO) supports strong coordination, collaboration, and communication among public health, healthcare providers, parents and caregivers, and community partners at the local, regional, state, and federal levels to increase human papillomavirus (HPV) vaccination coverage in both males and females according to the recommendations of the Advisory Committee on Immunization Practices (ACIP). Local health departments should implement and adapt programs and policies to increase vaccination rates in their communities.

NACCHO encourages local health departments to develop a comprehensive approach to increasing HPV vaccination rates that includes the following:

Encouraging providers to make strong and consistent HPV vaccine recommendations and educating them on the most effective way of communicating these recommendations;

 Supporting communication campaigns to educate parents and caregivers about the importance of HPV vaccination for cancer prevention and encouraging parents and caregivers to vaccinate their children;

 Educating adolescents directly about HPV and other adolescent health issues;

 Developing relationships with non-traditional vaccine providers such as pharmacists and expanding their role in increasing HPV vaccination rates;

 Developing relationships with adolescent health groups, hospital systems, healthcare and cancer coalitions, school systems, and provider groups to support HPV vaccination;

 Developing, using, and sharing best practices to increase HPV vaccination rates and close the gap between male and female vaccination rates;

 Reducing missed opportunities and increasing HPV vaccine series completion through assessment and system-based changes using tools such as AFIX, reminder/recall, standing orders, and Immunization Information Systems;

 Implementing evaluation and data collection processes to demonstrate the impact of HPV vaccine promotion initiatives;

 Seeking opportunities to address systemic barriers to vaccination such as health inequity and a lack of access to healthcare; and

 Establishing themselves as trusted sources of information about HPV and other vaccines in their community.

Local health departments should consider developing or maintaining the capacity to bill third-party payers for the vaccine and administration to ensure long-term programmatic sustainability.

NACCHO also encourages continued state and federal support of local health department efforts to establish HPV initiatives, sustain program activities, and collaborate with public health partners.


HPV is the most common sexually transmitted infection in the United States and is responsible for nearly 26,000 new cases of cancer each year. HPV infections are responsible for the majority of cervical cancer and have been increasingly linked to cancers of the anus, penis, throat, vagina, and vulva.1,2 The combined cost of HPV-associated cancers and other conditions is estimated to be $8 billion per year in the United States.3

Immunization has proven to be one of the most effective and safest public health interventions available. In 2006, ACIP recommended the HPV vaccine for routine vaccination of adolescent females between ages 11–12.4 In 2011, ACIP expanded the recommendation to include adolescent males.5 Although the President’s Cancer Panel considers HPV vaccination a top priority in cancer prevention, coverage rates remain significantly low and fall short of the Healthy People 2020 target of 80% for both males and females.6,7 According to 2013 National Immunization Survey data, 57.3% of females and 34.6% of males received at least one dose of HPV vaccine compared to 86% for tetanus, diphtheria, and pertussis (Tdap) and 77.8% for meningococcal conjugate vaccines. This demonstrates both the disparity between male and female vaccination rates and the feasibility of high adolescent vaccine coverage.8,9

However, providers often miss opportunities to vaccinate adolescents during routine healthcare visits as evidenced by the fact that nearly two-thirds of 11–12 year olds are not vaccinated for HPV at office visits where they receive other vaccines.10 If these missed opportunities were avoided, approximately 93% of 13- to 17-year-old females would have at least initiated the series by 2012.11 Healthcare provider peer-to-peer education can be effective in overcoming challenges for the collective uptake of adolescent vaccines; therefore, it may be useful in reducing missed opportunities and encouraging providers to make a strong recommendation. This is especially important since a physician’s recommendation is the strongest predictor of HPV vaccination among adolescents.12, 13

Increasing access to healthcare may also lead to increased HPV vaccination rates since adolescents with health insurance and high healthcare utilization are associated with higher vaccination coverage.14 Misinformation about HPV and the HPV vaccine are pervasive in many communities, which can be overcome through effective communication campaigns. Racial disparities also exist in HPV vaccination coverage, as lower rates of series completion have been shown in African-American females compared to other groups15; thus addressing systemic issues such as health inequity may help increase vaccination rates.

Resources for Local Health Departments from NACCHO’s HPV Prevention Project

NACCHO’s first cohort of ten local health departments are implementing their action plans to identify strategies to improve HPV vaccination rates. Read these local health departments’ stories to learn about their ongoing HPV prevention efforts:

Additionally, NACCHO’s Guide to HPV Resources for Local Health Departments assists local health departments with increasing HPV vaccination rates. This collection of fact sheets, webinars, infographics, print material, videos, and more can assist local health departments with the development of HPV projects and vaccination campaigns. Download the Guide



1. International Agency for Research on Cancer. (2007). Monographs on the evaluation of carcinogenic risks to humans. Volume 90: human papillomaviruses. Lyon, France: World Health Organization, International Agency for Research on Cancer.

2. Gillison, M.L., Alemany, L., Snijders, P.J., Chaturvedi, A., Steinberg, B.M., Schwartz, S., et al. (2012). Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine, 30(5 Suppl.), F34-54.

3. Chesson, H.W., Ekwueme, D.U., Saraiya, M., Watson, M., Lowy, E.R., & Markowitz, L.E. (2012). Estimates of the annual medical costs of the prevention and treatment of disease associated with human papillomaviruses in the United States. Vaccine, 30(42), 6016-9.

4. Markowitz, L.E., Dunne, E.F., Saraiya. M., Lawson, H.W., Chesson, H., & Unger, E.R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 56(RR-2), 1-24.

5. CDC. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report, 60(50), 1705-8.

6. National Cancer Institute. (2014). Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Retrieved April 4, 2014, from

7. Department of Health and Human Services. Healthy People 2020 webpage. Retrieved January 6, 2015, from

8. CDC. (2014). Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States. Morbidity and Mortality Weekly Report, 63(29), 620-4.

9. Elam-Evans, L.D., Yankey, D., Jeyarajah, J., Singleton, J.A., Curtis, C.R., MacNeil, J., (2014). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years — United States, 2013. Morbidity and Mortality Weekly Report, 63(29), 625-33.

10. Stokley, S., Cohn, A., Jain, N., & McCauley, M.M. (2011). Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: Evaluation of the 2009 national immunization survey-teen. Archives of Pediatrics & Adolescent Medicine, 165(9), 813-8.

11. CDC. (2013). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013—United States. Morbidity and Mortality Weekly Report, 62(29), 591-5.

12. Gargano, L.M., Herbert, N.L., Painter, J.E., Sales, J.M., Morfaw, C., Rask, K., et al. (2013). Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Human Vaccines & Immunotheraputics, 9(12), 2627-33.

13. Reiter, P.L., McRee, A.L., Pepper, J.K., Gilkey, M.B., Galbraith, K.V., & Brewer, N.T. (2013). Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. American Journal of Public Health, 103(8), 1419-27.

14. Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., & Tooher, R. (2012). Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine, 30, 3546-56.

15. Curtis, C.R., Dorell, C., Yankey, D., Jeyarajah, J., Chesson, H., Saraiya, M., et. al. (2014). National human papillomavirus vaccination coverage among adolescents aged 13-17 years — National Immunization Survey — Teen, United States, 2011. Morbidity and Mortality Weekly Report, 63(2), 61-70.

Record of Action

Proposed by NACCHO Immunization Workgroup

Adolescent Health Beyond Borders

Adolescent Health Beyond Borders

Adolescent Health Insider

Adolescent Health Beyond Borders

July 2016

Roughly 1.8 billion adolescents and young adults between the ages of 10 and 24 live in today’s world, representing the largest generation of adolescents in human history. These young people face never-before-seen shifts in populations, economies, technology, health, and the environment. The benefits of helping today’s adolescents navigate these shifts and develop into healthy adults extend to future generations.

In recognition of the critical need to support adolescents, The Lancet Commission on Adolescent Health and Wellbeing released a report on the current state of adolescent health around the world, and the challenges and opportunities for addressing it. Below are some key findings from the report.

Defining Adolescence

Why Should We Focus on Adolescence?

In the United States, early childhood is widely recognized as a critical developmental period, but adolescence garners far less attention, despite its importance in establishing adult health and stability. During the teen and young adult years, the tremendous physical and mental changes that adolescents undergo prime them for creating their own lives beyond their families. While timing and appearance vary, adolescents pass key milestones on the road to adulthood, including completing education, finding a job, and establishing romantic partnerships and/or other social connections.

As the phase in life directly preceding adulthood, adolescence has large and immediate impacts not only on young people themselves, but future generations. Today’s adolescents are the next in line to fill the workforce and create families. Through their development and completion of milestones, adolescents build and acquire the health, financial independence, and social capital that they will use not only in their adult lives but that they will pass on to their children. Taking action for adolescent health now ensures the health of future generations.

What Does Adolescent Health Look Like Today?

The increasing number of adolescents is partly related to advances in health and medicine, particularly in eliminating infectious diseases. However, this progress has not spread evenly across the globe, and as a result, countries have radically different adolescent health profiles.

The Lancet Commission categorized the global burden of disease into three categories, each with their own challenges:

  • About one third of adolescents (661 million) live in non-communicable disease (NCD) predominant countries. Most high-income countries fall into this category, including the United States. The top adolescent health issues are related to mental and substance use disorders (e.g., depression, tobacco use) and chronic physical diseases (e.g., diabetes).
  • Roughly one in eight adolescents (219 million) lives in an injury excess country, where unintentional injury and violence are the primary causes of disability and death.
  • Half of all adolescents (917 million) live in multi-burden countries, where both injury and NCDs are a major concern along with infectious disease, malnutrition, and other conditions related to poverty. Most of the countries in Africa fall into this category, along with India and its neighbors, and several Southeast Asian island nations.

Additionally, wide variation may exist within particular countries. For example, four of China’s provinces could be classified as injury excess, even though the country is classified as NCD prominent overall.

Health is also influenced by varied social and structural factors known as the social determinants of health. While a number of social determinants impact adolescents, The Lancet Commission specifically identifies four: family, peers, education/employment, and the media. What these determinants look like and how they affect health are rapidly changing, creating unprecedented challenges and opportunities for adolescent health.

While the adolescent health issues facing countries and localities differ, all communities can take action to support adolescent health and development.

What Can We Do to Promote Adolescent Health?

Addressing the health needs of today’s adolescents can seem like a daunting task, but there are several key opportunities that offer hope. In particular, guaranteeing and supporting adolescents’ ability to access and complete their secondary education has been named as the single best investment for their health and well-being. Other opportunities identified by the Commission include addressing preventable and treatable adolescent health conditions (e.g., HIV/AIDS, injury, infectious diseases) and establishing systems that train, mentor, and encourage the participation of youth health advocates that make health care more responsive to adolescents’ needs.

The report points out that the most powerful actions for adolescent health cut across sectors and include multiple components. OAH’s national call-to-action, Adolescent Health: Think, Act, Grow® (TAG), seeks to foster this multi-level, multi-sectoral collaboration. You can use the TAG action steps to support adolescent health in your work.

Over the next four OAH Picks, OAH will delve further into The Lancet‘s primary social determinants of health affecting adolescents, how they relate to the outstanding opportunities for adolescent health, and tools that youth-serving professionals and others can use to promote adolescent health.

Motor and sensory clinical findings in girls vaccinated against the human papillomavirus from Carmen de Bolivar, Colombia.

Motor and sensory clinical findings in girls vaccinated against the human papillomavirus from Carmen de Bolivar, Colombia.

Lengthy post. #NOHPVmandateRI


Original research

By Pompilio Martinez, MD
Alumnus, School of Medicine, National University of Colombia
Ex-investigator, Colombian National Institute of Health, Bogota, Colombia


Here I describe neurological symptoms of 62 girls who were immunized against the human papilloma virus (HPV). Most participants (61) are Colombian and received the quadrivalent HPV vaccine Gardasil and a girl from Mexico received the bivalent Cervarix vaccine. The average age was 14.5 years (SD 2.1). This survey reveals an overall pattern of peripheral nervous system damage as demonstrated by complaints of inflammatory and neuropathic pain syndromes in the head, back, chest, arms and legs. There were also sensory and motor syndromes with upper and lower limb numbness and tingling (paraesthesia), muscle weakness and difficulty walking (paresis) accompanied by tremors, muscle spasms and twitches (abnormal movements). Most symptoms appeared after the second vaccine dose, which agrees with greater antibody titers seen in booster dose immunizations. A…

View original post 7,972 more words

How to Nip HPV Vaccine Mandates in the Bud: Lessons from Pennsylvania

From PA. #NOHPVmandateRI #NOHPVmandatePA


MANY OF MY FELLOW sojourners on Facebook have thanked me for fighting back at the – read this slow – proposal to write a proposal for a mandate for HPV vaccination in Allegheny County, PA that the Allegheny County Board of Health (ACBH) was contemplating.  While it’s true I’ve been involved the spotlight really goes to the ladies of the local contingent of the Pennsylvanian Coalition for Informed Consent and the members of the general public who stood up and said #nohpvmandatePA.

I was invited to participate in a meeting w/these truth warriors and defenders of health rights, and I can attest that no board, no committee, no legislative body will ever succeed in mandating HPV in the Pennsylvania as long as they have to deal with this coalition.  They are organized, informed, dedicated, and, most importantly, growing.

My personal experience in this is consistent with my own growing awareness…

View original post 3,199 more words

Awareness Campaign~ counter RI Dept of Health

Awareness Campaign~ counter RI Dept of Health

The RI Dept of Health recently sent out postcards direct to minors and also robo called homes of 7th and 8th grade parents in regards to vaccinations. Some calls were for multiple vaccines and some focused on the HPV vaccine. None of this effort gave risks vs benefits data or disclosed exemption options.

You can read our press release about this topic by clicking HERE ==> PRESS RELEASE. Help bring attention to this matter by posting this press release direct at media accounts. The more that show they are not happy about this the more the media might pay attention. Hashtag #NOHPVmandateRI


We are working to counter the efforts of the Dept of Health with informed consent via our Awareness Campaign. They have over a half million dollars to which they can delegate to different forms of marketing. We don’t need that much to still be loud and keep citizens informed.

Our current goal is $2500, If you give $8 or $80 or $800 it makes a BIG difference. Help with whatever amount you are able. 100 people giving $25 puts us at our goal. This is not just a RI issue, this is a national issue. RI reports the strategies to the National Vaccine Advisory Committee, along with their % of vaccinated children in the age range. NVAC is already advocating for minor consent without parental consent of the HPV vaccine, we need to show that we can and we WILL fight back. The nation leaders need to know that mandating HPV vaccines on any level anywhere in the USA is not acceptable.

Please donate today donate-now-heart-speech-bubble_138893771

This is very important issue on so many levels.

  • Mandating a vaccine for a disease that does not impact the classroom
  • Marketing direct to minors for medical procedures
  • Calling homes with automated messages, for a vaccine that this state has one of the highest vaccination rates in the country.
  • Neglecting informed consent

The RI Dept of Health has never been challenged by the public like we have done in the last year. They stepped up their efforts, we need to STAND UP STRONG. It is time to put them on the Defense. The more you give the more we can do.





We sent out an email that it seems many may not have received, you can find that message here, if you didn’t get a message recently.

Follow on Twitter @MyRightsRI

Tax Dollars Used To Market Controversial HPV Vaccine Mandate

Tax Dollars Used To Market Controversial HPV Vaccine Mandate

Subject: Tax Dollars Used To Market Controversial HPV Vaccine Mandate

PRESS RELEASE for Immediate Release

JULY 5, 2016

Rhode Islanders against mandated HPV vaccinations (#NOHPVmandateRI) calls out the RI Dept, of Health

Recently, the RI Dept. of Health began robo-calls to households of children entering the seventh and eighth grade urging students to get vaccinations. This call outlines that HPV (human papillomavirus) is a dangerous disease. In never mentions that most cases of HPV are asymptomatic and that 90% of all cases clear themselves within two years. It does not inform that there are religious exemptions available for vaccinations in Rhode Island. Rhode Islanders against mandated HPV vaccinations (#NOHPVmandateRI)

The Dept. of Health doubled their efforts with postcards. Each one was sent in the name of the student and was marketing vaccinations. Direct health decision information mailed and marketed to minors. When did it become appropriate to bypass the parent for a medical procedure? Why is proper informed consent not being utilized? Why is there no mention of the religious or medical exemptions?

In 2014, the same year the vaccine was mandated, the RI Dept. of Health received a grant for the HPV vaccination of over $638,000. The grant money line item breakdown shows that none of the money is to purchase the vaccine or to subsidize the vaccine cost. The grant for over a half million dollars is to market one specific vaccination. Federal grant money, our tax dollars, was awarded in this large sum to the smallest state in the nation. So far none of their efforts have included risks vs benefits, which is essential to any medical procedure, or that Rhode Island has exemptions for parents. They have not yet returned a phone call from a group member, to determine if the grant was part of the National Vaccine Advisory Committee test market campaign of 2014.

“This marketing to minors is completely inappropriate,” says Aimee Gardiner, Director of #NOHPVmandateRI. “I do not feel it is a good use of tax dollars, to increase a push on vaccination especially for a vaccine this state already shows a high rate of students have received. It is concerning that a Dept that is supposed to be dedicated to Health and well-being does not respect informed consent, and then crosses into marketing at minors.”

“Parents are upset, and they have every right to be” Christine Waldeck of Providence adds. “I find it appalling that the automated call ends with ‘vaccines are safe, and vaccines work’, they are not one size fits all, some kids are seriously injured as evidenced by the billions of dollars in payouts to families from the National Vaccine Injury Compensation Program.”

Rhode Islanders against mandated HPV vaccinations strongly encourages anyone not fully comfortable with receiving the HPV vaccination to file a religious exemption form. The RI HPV Info pack has the exemption form included, it is located at


Media Contact

Aimee Gardiner, Director

Rhode Islanders against mandated HPV vaccinations ~ 4014062647

PDF file of press release